Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC

Kinase domain duplications of the epidermal growth factor receptor (EGFR‐KDD) have been identified and implicated to be oncogenic in nonsmall cell lung cancers (NSCLCs). However, its prevalence and clinical contributions in lung cancer are largely unknown. Here, we conducted a multicenter record rev...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Cancer
Autors principals: Wang, Jinguang, Li, Xingya, Xue, Xingyang, Ou, Qiuxiang, Wu, Xue, Liang, Ying, Wang, Xiaonan, You, Ming, Shao, Yang W., Zhang, Zhihong, Zhang, Shucai
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2018
Matèries:
Cancer Genetics and Epigenetics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590137/
https://ncbi.nlm.nih.gov/pubmed/30255937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31895
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars